Molecular Machinery of the Triad Holin, Endolysin, and Spanin: Key Players Orchestrating Bacteriophage-Induced Cell Lysis and their Therapeutic Applications

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Samir S.

Journal: Protein and Peptide Letters

Publisher: Bentham Science Publishers

Publication Date: February 2024

Volume / Issue: Volume 31 / Issue 2

Pages: 85–96

ISSN: 9298665

DOI: 10.2174/0109298665181166231212051621

Scopus: View on Scopus

PubMed: 38258777

Document Type: Short survey


Authors and Affiliations

Samir S., Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

Phage therapy, a promising alternative to combat multidrug-resistant bacterial infections, harnesses the lytic cycle of bacteriophages to target and eliminate bacteria. Key players in this process are the phage lysis proteins, including holin, endolysin, and spanin, which work synergistically to disrupt the bacterial cell wall and induce lysis. Understanding the structure and function of these proteins is crucial for the development of effective therapies. Recombinant versions of these proteins have been engineered to enhance their stability and efficacy. Recent progress in the field has led to the approval of bacteriophage-based therapeutics as drugs, paving the way for their clinical use. These proteins can be combined in phage cocktails or combined with antibiotics to enhance their activity against bacterial biofilms, a common cause of treatment failure. Animal studies and clinical trials are being conducted to evaluate the safety and efficacy of phage therapy in humans. Overall, phage therapy holds great potential as a valuable tool in the fight against multidrug-resistant bacteria, offering hope for the future of infectious disease treatment. © 2024 Bentham Science Publishers.


Keywords

bacteriophage; holin; Multidrug-resistant; multigene lysis; phage endolysin; spanin; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriolysis; Bacteriophages; Drug Resistance, Multiple, Bacterial; Endopeptidases; Humans; Phage Therapy; Viral Proteins; antiinfective agent; ceftriaxone; daptomycin; endolysin; gentamicin; unclassified drug; proteinase; viral protein; Acinetobacter baumannii infection; acne; amino terminal sequence; antimicrobial activity; bacterial infection; biofilm; bloodstream infection; bovine mastitis; carboxy terminal sequence; cardiovascular infection; cell membrane; clinical evaluation; cytolysis; drug approval; eczema; food poisoning; genetic code; human; inner membrane; lung infection; molecular biology; multidrug resistant bacterium; nonhuman; outer membrane; pneumococcal infection; progeny; protein domain; protein structure; rosacea; safety procedure; Short Survey; skin disease; therapy effect; treatment failure; upper respiratory tract infection; animal; bacterium; chemistry; drug effect; genetics; metabolism; multidrug resistance; procedures; therapy; virology


Citation Information

Scopus Citations: 18


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

Transcriptome analysis for Schistosoma vector snail’s Oncomelania hupensis exposed to silver nanoparticles

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region